Volume 131, Issue 4, Pages (October 2006)

Slides:



Advertisements
Similar presentations
Volume 124, Issue 7, Pages (June 2003)
Advertisements

Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Volume 145, Issue 6, Pages (December 2013)
Volume 146, Issue 2, Pages e3 (February 2014)
Volume 137, Issue 3, Pages (September 2009)
Volume 140, Issue 2, Pages e2 (February 2011)
Volume 148, Issue 5, Pages e4 (May 2015)
Volume 145, Issue 6, Pages (December 2013)
Volume 134, Issue 7, Pages (June 2008)
Volume 133, Issue 6, Pages (December 2007)
Volume 136, Issue 1, Pages (January 2009)
Volume 132, Issue 1, Pages (January 2007)
Volume 135, Issue 2, Pages e3 (August 2008)
Volume 134, Issue 5, Pages (May 2008)
Daniel K. Podolsky, Guido Gerken, Annette Eyking, Elke Cario 
Volume 133, Issue 2, Pages (August 2007)
Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human.
Volume 138, Issue 5, Pages e4 (May 2010)
Wael M ElShamy, Patrik Ernfors  Neuron 
Glial Cell–Derived Neurotrophic Factor Enhances Synaptic Communication and 5- Hydroxytryptamine 3a Receptor Expression in Enteric Neurons  Fanning Zeng,
Volume 141, Issue 3, Pages e8 (September 2011)
Volume 143, Issue 4, Pages e9 (October 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 134, Issue 1, Pages (January 2008)
Volume 132, Issue 5, Pages (May 2007)
Volume 146, Issue 2, Pages e1 (February 2014)
Volume 138, Issue 7, Pages (June 2010)
Nitric Oxide–Sensitive Guanylyl Cyclase Is Dispensable for Nitrergic Signaling and Gut Motility in Mouse Intestinal Smooth Muscle  Dieter Groneberg, Peter.
Volume 128, Issue 5, Pages (May 2005)
Volume 140, Issue 1, Pages (January 2011)
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
Volume 136, Issue 4, Pages e3 (April 2009)
Loss of Raf Kinase Inhibitor Protein Promotes Cell Proliferation and Migration of Human Hepatoma Cells  Han Chu Lee, Bo Tian, John M. Sedivy, Jack R.
Volume 141, Issue 4, Pages (October 2011)
Volume 136, Issue 4, Pages (April 2009)
Volume 137, Issue 3, Pages (September 2009)
Volume 139, Issue 1, Pages e6 (July 2010)
Volume 134, Issue 3, Pages (March 2008)
E. Cario, G. Gerken, D.K. Podolsky  Gastroenterology 
Nitric Oxide Not Carbon Monoxide Mediates Nonadrenergic Noncholinergic Relaxation in the Murine Internal Anal Sphincter  Satish Rattan, Raymond F. Regan,
Volume 139, Issue 4, Pages (October 2010)
Volume 139, Issue 6, Pages (December 2010)
Neuronal Serotonin Regulates Growth of the Intestinal Mucosa in Mice
Volume 132, Issue 4, Pages (April 2007)
Volume 134, Issue 2, Pages e3 (February 2008)
Volume 133, Issue 1, Pages (July 2007)
Volume 141, Issue 2, Pages e4 (August 2011)
Epidermal Growth Factor Receptor–Mediated Proliferation of Enterocytes Requires p21waf1/cip1 Expression  George Sheng, Kathryn Q. Bernabe, Jun Guo, Brad.
Volume 145, Issue 1, Pages e3 (July 2013)
Volume 134, Issue 4, Pages (April 2008)
Suppression of Apoptosis, Crypt Hyperplasia, and Altered Differentiation in the Colonic Epithelia of Bak-Null Mice  Carrie A. Duckworth, D. Mark Pritchard 
Volume 143, Issue 4, Pages e4 (October 2012)
The Zinc Transporter Zip14 Influences c-Met Phosphorylation and Hepatocyte Proliferation During Liver Regeneration in Mice  Tolunay Beker Aydemir, Harry.
Volume 82, Issue 7, Pages (October 2012)
Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth  Joanne Soong, Yulin Chen, Elina.
Volume 129, Issue 5, Pages (November 2005)
Volume 125, Issue 1, Pages (July 2003)
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 139, Issue 6, Pages (December 2010)
Volume 139, Issue 4, Pages (October 2010)
Volume 68, Issue 2, Pages (August 2005)
Volume 7, Issue 1, Pages (January 2008)
Volume 141, Issue 3, Pages (September 2011)
Inducible Nitric Oxide Synthase Up-Regulates Notch-1 in Mouse Cholangiocytes: Implications for Carcinogenesis  Norihisa Ishimura, Steven F. Bronk, Gregory.
Volume 129, Issue 6, Pages (December 2005)
Abnormalities of Prostaglandins and Cyclooxygenase Enzymes in Female Patients With Slow-Transit Constipation  Ping Cong, Victor Pricolo, Piero Biancani,
Volume 116, Issue 1, Pages (January 1999)
Volume 117, Issue 3, Pages (September 1999)
Volume 121, Issue 4, Pages (October 2001)
Orexin Synthesis and Response in the Gut
Presentation transcript:

Volume 131, Issue 4, Pages 1164-1178 (October 2006) Glial-Derived Neurotrophic Factor Modulates Enteric Neuronal Survival and Proliferation Through Neuropeptide Y  Mallappa Anitha, Bindu Chandrasekharan, Joana R. Salgado, Eric Grouzmann, Simon Mwangi, Shanthi V. Sitaraman, Shanthi Srinivasan  Gastroenterology  Volume 131, Issue 4, Pages 1164-1178 (October 2006) DOI: 10.1053/j.gastro.2006.07.019 Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 1 GDNF increases NPY mRNA and protein expression. (A) RNA was isolated from enteric neurons cultured in the presence or absence of GDNF for 24 hours and amplified for GAPDH (loading control) and NPY. The presence of GDNF causes an increase in NPY mRNA. (B) Quantitative real-time PCR showing the relative level of expression of NPY (GDNF vs vehicle) after normalization to GAPDH expression. Results are mean ± SE. n = 9, ***P < .001. (C and D) Enteric neurons cultured in the presence of vehicle, GDNF, or NPY for 24 hours were assessed for peripherin (red)/NPY (green) and the results expressed as percentage NPY-positive neurons. GDNF induced an increase in the number of NPY+ neurons (arrows pointing at yellow neurons). Results are mean ± SE. n = 3, ***P < .001. Scale bar = 20 μm. (E) Enteric neurons were cultured in the presence or absence of GDNF (48 hours), and medium was assayed for NPY and PYY by ELISA. GDNF induced a significant release of NPY but not PYY into the culture medium compared with vehicle. Results are mean ± SE. n = 3, **P < .01. P value is with respect to neurons cultured in the presence of vehicle. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 2 GDNF-induced proliferation and survival of enteric neurons is reduced in the presence of NPY siRNA. (A) Enteric neurons in the N2 medium were transfected with control Cyclophilin B or NPY-specific siRNA for 24 hours and were subsequently cultured for 24 hours in the presence or absence of GDNF. BrdU was added to the medium 24 hours prior to the fixation of neurons and the percentage of BrdU+/peripherin+ neurons was determined to assess the proliferation, n = 4. (B) Transfected enteric neurons were assessed for apoptosis using the double labeling of TUNEL and peripherin, n = 3. (C and D) To study the NPY siRNA specificity, transfected enteric neurons were stained for NPY (green)/peripherin (red), n = 3. Results are mean ± SE. ***P < .001, **P < .01, *P < .05. Scale bar = 20 μm. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 3 GDNF induces proliferation of enteric neurons through NPY. (A and B) Enteric neurons treated with vehicle, NPY, or GDNF in the presence or absence of either the NPY-Y1 receptor antagonist (BIBP3226) or the PI-3-kinase inhibitor (LY294002) were maintained in culture for 48 hours and fixed. BrdU was added to the medium 24 hours prior to fixation. The percentage of BrdU+ (green)/peripherin+ (red) neurons was determined to assess proliferation. Arrows point to the BrdU+ neurons. Exposure of enteric neurons to NPY (48 hours) significantly increased proliferation similar to GDNF. GDNF- and NPY- induced proliferation of enteric neurons was inhibited by both BIBP3226 and LY294002, n = 4. Scale bar = 20 μm. (C and D) The total number of cells (DAPI, blue) and neurons (peripherin, red) per well were assessed under the stated culture conditions, n = 2. Results are mean ± SE. ***P < .001, **P < .01. P value is with respect to the neurons cultured in the absence of antagonist (B) or vehicle (D) in each respective condition. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 4 GDNF suppresses apoptosis of enteric neurons through NPY. (A and B) Enteric neurons treated with vehicle, NPY, or GDNF in the presence or absence of BIBP3226 or LY 294002 for 24 hours were assessed for apoptosis by the TUNEL (green)/peripherin (red) method. Exposure of enteric neurons to NPY or GDNF significantly reduced apoptosis compared with vehicle. This effect was inhibited by BIBP3226 and LY294002. Arrows show the apoptotic cells with condensed nuclei. Results are mean ± SE. n = 3, ***P < .001, **P < .01, *P < .05, scale bar = 20 μm. P value is with respect to the neurons cultured in the absence of antagonist in each respective condition. (C and D) Western blot analysis of cleaved caspase-3 in enteric neurons cultured in the presence or absence of NPY for 24 hours. β-Actin was used as a loading control. There was a significant reduction in the expression of cleaved caspase-3 in NPY-treated cells compared with vehicle. Results are ratio ± SE. n = 3, ***P < .001. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 5 NPY activates the PI-3-kinase pathway. Cell lysates were obtained from enteric neurons treated with vehicle, NPY (A and B), or GDNF (C and D) with or without LY294002 for 30 minutes, and Western blot was performed. GDNF and NPY significantly increased the phosphorylation of Akt compared with vehicle. This was inhibited in the presence of the PI-3-kinase inhibitor LY294002. Results are ratio (pAkt/Akt) ± SE. n = 3, ***P < .001. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 6 GDNF and NPY increase nNOS+ enteric neurons but not ChAT+ neurons. Primary enteric neurons were treated with vehicle, NPY, GDNF, or NPY + LY294002 for 24 hours, fixed and assessed for nNOS (red) and peripherin (green) (A and B) or ChAT (green) and peripherin (red) (C and D). n = 4. Scale bar = 20 μm. (E and F) Enteric neurons were transfected with control Cyclophilin B siRNA or NPY-specific siRNA for 24 hours and then cultured for an additional 24 hours in the presence or absence of GDNF, fixed and assessed for nNOS and ChAT. n = 3. Results are mean ± SE. **P < .01, *P < .05. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 7 NPY colocalizes with nNOS. Primary enteric neurons were treated with GDNF for 24 hours, fixed and assessed for nNOS (red) and peripherin (green) (A) or ChAT (green) and peripherin (red) (B). (C) Percentage NPY colocalization with nNOS or ChAT is shown. Results are mean ± SE. n = 3, ***P < .001. Scale bar = 20 μm. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 8 Expression and effects of NPY at different developmental stages. (A) NPY is expressed in the proximal intestine of E12.5 rat embryos and extends into the distal intestine in E16.5 rat embryos. NPY is stained with cy3 (red) and peripherin with FITC (green). Arrows show the NPY+ ganglia in E12.5 and E16.5 gut. In the E16.5 intestine, the intestinal layers are labeled L (lumen), M (mucosa), SM (submucosal), CM (circular muscle layer), and LM (longitudinal muscle layer). Scale bar for A = 20 μm. (B and C) The effect of GDNF and NPY on apoptosis and proliferation was assessed in rat embryos at different developmental stages. NPY affects proliferation more in the early stages and apoptosis in the later embryonic stages. (D) nNOS neurons were assessed by immunostaining at different developmental stages. Both GDNF and NPY caused an increase in the number of nNOS+ neurons starting from developmental stage E12.5. (E) Immunohistochemistry for NPY was performed to demonstrate the absence of NPY expression in NPY−/− mice. The ganglia are stained with peripherin (green) and NPY (red). The overlap of red and green is seen in NPY+ neurons. (F) GDNF did not suppress the apoptosis in enteric neurons cultured from NPY−/− mice. The effect of GDNF and NPY on apoptosis in enteric neurons obtained from NPY−/− mice was assessed by the peripherin/TUNEL method. Results are mean ± SE. ***P < .001, **P < .01, *P < .05, scale bar for E = 100 μm. P value is with respect to the neurons cultured in the presence of vehicle in each respective condition. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 9 NPY−/− mice have reduced colonic nNOS+ containing neurons compared with WT mice. (A–C) Longitudinal muscle strips along with myenteric plexus from mouse colon were fixed and stained for nNOS+ neurons using NADPH-diaphorase staining. The nNOS+ neurons and large fibers (arrows) of the myenteric plexus were significantly decreased in the colon of the NPY−/− mice compared with WT. (D–F) ChAT+ neurons and large fibers (arrows) of the myenteric plexus were similar in the NPY−/− and WT colon. Total number of neurons was assessed by peripherin staining (G and H). (I) nNOS expression in WT and NPY−/− mouse stomachs and colons was assessed by Western blot. Scale bar = 100 μm in A and D and 20 μm in G. Results are mean ± SE. n = 6 in each group. **P < .01, *P < .05. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions

Figure 10 Altered motility in NPY−/− mice. (A) Gastric emptying and intestinal transit was assessed in WT and NPY−/− mice. Gastric emptying was significantly higher in NPY−/− compared with WT mice. Results are mean ± SE. n = 4, *P < .05. (B) Intestinal transit was significantly lower in NPY−/− compared with WT mice. Results are mean ± SE. n = 4, *P < .05. (C) Assessment of colonic relaxation with electrical field stimulation in isolated colonic muscle strips containing the myenteric plexus. Transmural electrical field stimulation (100 V/48 V, 20 Hz, 5 msecond [ms] pulse, 60 s)-evoked relaxation of the proximal colon was significantly impaired in NPY−/− compared with WT mice. Results are mean ± SE. n = 4, *P < .05, **P < .01. (D) Representative tracings of electrical field stimulation. The x-axis represents time, and the y-axis represents force in millinewtons (mN). The arrows represent when the electrical stimulation was turned on and off. (E) Effect of L-NAME on electrical field-induced stimulation. The isolated muscle strips from WT mice were pretreated with L-NAME or buffer alone for 30 minutes, and EFS was performed at 100 V, 20 Hz, 5 ms, 60 s. The tracing shows the lack of relaxation in the presence of L-NAME. Gastroenterology 2006 131, 1164-1178DOI: (10.1053/j.gastro.2006.07.019) Copyright © 2006 American Gastroenterological Association (AGA) Institute Terms and Conditions